Johnson, C. D., Puntis, M., Davidson, N., Todd, S. ORCID: https://orcid.org/0000-0002-9981-923X and Bryce, R. (2001) Randomized, dose-finding phase III study of lithium gamolenate in patients with advanced pancreatic adenocarcinoma. British Journal of Surgery, 88 (5). pp. 662-668. ISSN 0007-1323 doi: https://doi.org/10.1046/j.0007-1323.2001.01770.x

Stallard, N., Whitehead, J., Todd, S. ORCID: https://orcid.org/0000-0002-9981-923X and Whitehead, A. (2001) Stopping rules for phase II studies. British Journal of Clinical Pharmacology, 51 (6). pp. 523-529. ISSN 0306-5251 doi: https://doi.org/10.1046/j.0306-5251.2001.01381.x

Todd, S. ORCID: https://orcid.org/0000-0002-9981-923X and Sahdra, M. (2001) A case study of the effect of covariate adjustment in a sequential survival clinical trial. Journal of Biopharmaceutical Statistics, 11 (4). pp. 297-311. ISSN 1054-3406 doi: https://doi.org/10.1081/BIP-120008850

Todd, S. ORCID: https://orcid.org/0000-0002-9981-923X, Whitehead, A., Stallard, N. and Whitehead, J. (2001) Interim analyses and sequential designs in phase III studies. British Journal of Clinical Pharmacology, 51 (5). pp. 394-399. ISSN 0306-5251 doi: https://doi.org/10.1046/j.1365-2125.2001.01382.x

Whitehead, J., Whitehead, A., Todd, S. ORCID: https://orcid.org/0000-0002-9981-923X, Bolland, K. and Sooriyarachchi, M. R. (2001) Mid-trial design reviews for sequential clinical trials. Statistics in Medicine, 20 (2). pp. 165-176. ISSN 0277-6715 doi: https://doi.org/10.1002/1097-0258(20010130)20:2<165::AID-SIM649>3.0.CO;2-A

Whitehead, J., Zhou, Y., Stallard, N., Todd, S. ORCID: https://orcid.org/0000-0002-9981-923X and Whitehead, A. (2001) Learning from previous responses in phase I dose-escalation studies. British Journal of Clinical Pharmacology, 52 (1). pp. 1-7. ISSN 03065251 doi: https://doi.org/10.1046/j.0306-5251.2001.01383.x